Pembayaran hanya melalui request quotation dan dilakukan setelah tim kami menghubungi Anda. Mohon cantumkan nomor WhatsApp aktif untuk konfirmasi pesanan & pembuatan invoice. Estimasi pengiriman 4-5 minggu setelah pembayaran.
Couldn't load pickup availability
Description
Belinostat (TCI B5888) is a potent hydroxamate-based histone deacetylase (HDAC) inhibitor supplied as a high-purity pharmaceutical research reagent for experimental use. It is primarily employed in preclinical oncology studies to investigate epigenetic mechanisms, gene expression modulation, and apoptosis induction in various cancer cell lines. This product serves as a valuable tool in HDAC inhibitor screening, drug resistance research, and combination therapy development.
![[3-(Bromomethyl)-1-tosylazetidin-3-yl]methanol (CAS 1041026-55-4) - TCI B5852 - AMI Scientific](http://amiscientific.com/cdn/shop/files/TCI2510B5852_08c96097-28a8-4e07-aa20-fbef24394b16.jpg?v=1767863600&width=533)
![(-)-4-tert-Butyl-2,6-bis[(4S,5S)-4,5-tetramethylene-1-(2,4,6-trimethylbenzenesulfonyl)imidazolin-2-yl]phenol (contains 5% Dichloromethane at maximum) (CAS 2102316-91-4) - TCI B6146 - AMI Scientific](http://amiscientific.com/cdn/shop/files/TCI2510B6146.jpg?v=1767093225&width=533)
